Table 2. Effect of areca nut and chrysanthemum oral gel on the area of ulcer and body weight changes in rats on the 2nd and 7th experimental days (n = 60).
| Groups | Clinical evaluation | |||||
|---|---|---|---|---|---|---|
| Area of ulcer changes (mm 2) | Body weight changes (g) | |||||
| 2 nd day | 7 th day | p | 2 nd day | 7 th day | p | |
| Negative control | 9.34 ± 0.69 | 5.24 ± 8.89 | 0.131 | 118.58 ± 5.29 | 117.25 ± 6.19 | 0.291 |
| Positive control | 10.10 ± 0.17 | 0.03 ± 0,01 | 0.000* | 109.58 ± 6.89 | 117.17 ± 7.50 | 0.005* |
| F1 | 10.04 ± 0.18 | 2.84 ± 0.44 | 0.000* | 119.17 ± 13.27 | 115.33 ± 14.46 | 0.000* |
| F2 | 10.08 ± 0.16 | 0.11 ± 0.07 | 0.000* | 116.83 ± 4.41 | 121.58 ± 4.87 | 0.010* |
| F3 | 10.08 ± 0.18 | 3.49 ± 0.42 | 0.000* | 120.50 ± 4.32 | 117.75 ± 6.82 | 0.028* |
Data are expressed as mean ± SD, * p < 0.05 (dependent t-test) denotes statistically significant differences between before and after treatment on the 2 nd and 7 th experimental days. Negative control: base gel; Positive control: triamcinolone acetonide orabase treatment; F1: 20% areca nut:80% chrysanthemum; F2: 50% areca nut:50% chrysanthemum; F3: 80% areca nut:20% chrysanthemum.